Physician profile
Brian Snyder
NPI 1689081895
$8,738.50
in general payments reported to CMS, 2019-2025
23 companies · $645 in 2025
The $645 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $340 · 2021: $3,097 · 2022: $1,439 · 2023: $2,301 · 2024: $566 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,343 · Travel and Lodging: $1,148 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,343.43 |
| Travel and Lodging | $1,148.19 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,460.27 | 2021-2024 | |
| Medtronic, INC. | $1,845.49 | 2021-2025 | Magnifuse Bone Graft, Stealthstation S8 Platform |
| Medical Device Business Services, INC. | $1,478.84 | 2019-2022 | |
| Globus Medical, INC. | $1,083.29 | 2021-2025 | Senza |
| Depuy Synthes Sales INC. | $622.84 | 2021-2023 | Teligen, Fibergraft Bg Morsels, Acis |
| Nevro Corp. | $405.85 | 2022-2024 | Senza |
| Zimmer Biomet Holdings, INC. | $132.51 | 2025 | Neuro Plating System |
| Stryker Corporation | $121.55 | 2024 | Universal Neuro 3, N/A |
| Baxter Healthcare | $111.37 | 2025 | Floseal |
| Novocure INC. | $94.55 | 2024-2025 | Optune Gio, Optune |
| Csl Behring | $85.23 | 2022-2024 | Kcentra |
| Servier Pharmaceuticals LLC | $46.17 | 2025 | |
| Lemaitre Vascular, INC. | $30.17 | 2023 | Anastoclip Gc 8cm (Medium) |
| Incyte Corporation | $26.46 | 2024 | Monjuvi, Pemazyre |
| Tersera Therapeutics LLC | $26.27 | 2025 | Zoladex |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.98 | 2023 | |
| Karl Storz Endoscopy-America | $24.11 | 2025 | N.A. |
| Lilly USA, LLC | $23.92 | 2024 | Verzenio, Jaypirca |
| Stemline Therapeutics INC. | $23.02 | 2024 | Orserdu |
| Boston Scientific Corporation | $22.59 | 2023 | |
| Sanara Medtech INC. | $20.02 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.96 | 2022 | |
| Corium, LLC | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.